Harvest One Announces Conditional Approval of Acquisition of ACMPR Licensed Medical Cannabis Producer and Swiss Medical Cannabis-Based Health Products Company

TORONTO, ONTARIO--(Marketwired - April 24, 2017) -


Harvest One Capital Inc. (NEX:WON.H) ("Harvest One" or the "Company") is pleased to announce that it has received conditional approval of the TSX Venture Exchange (the "Exchange") for the Company's previously announced acquisition from MMJ PhytoTech Limited ("MMJ") of 100% of the issued and outstanding shares of United Greeneries Holdings Ltd. and Satipharm AG from PhytoTechMedical (UK) Pty Ltd., a wholly owned subsidiary of MMJ (the "Acquisition").

The Company is also pleased to announce that an Amended Filing Statement dated as of April 19, 2017 filed in connection with the Acquisition has been posted on SEDAR and may be viewed under the Corporation's profile at www.sedar.com in accordance with Section 12.4(i) of Exchange Policy 2.4.

The closing of the Acquisition is expected to completed on April 26, 2017, and a further press release will be issued following closing.

In connection with the closing of the Acquisition, the net proceeds of the Company's previously announced private placement in support of the Acquisition (the "Offering") are expected to be released to the Company from escrow. Immediately prior to the closing of the Acquisition, the Company expects to complete a consolidation (the "Consolidation") on the basis of 1.79 pre-Consolidation common shares to one (1) post-Consolidation common share, and change its name from "Harvest One Capital Inc." to "Harvest One Cannabis Inc."

Subject to final acceptance of the Exchange, the common shares are expected to resume trading on the Exchange on or about April 28, 2017 under the symbol "HVST".

Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company's current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to the closing of the Acquisition and certain ancillary transactions contemplated thereby. These transactions are subject to a number of material risks, and there is no assurance that they will be completed on the terms or within the timeframes currently contemplated, or at all. The forward-looking information contained in this press release is made as of the date hereof and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward-looking information. The foregoing statements expressly qualify any forward-looking information contained herein.

This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities to be distributed pursuant to the Offering have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

All monetary references herein refer to Canadian dollars unless otherwise specified.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release nor have either of them in any way passed upon the merits of the qualifying transaction or in any way approved or disapproved of the contents of this release.

Contact Information:

MMJ PhytoTech Limited
Andreas Gedeon
Managing Director
+1 (250) 713-6302

Harvest One Capital Inc.
Anne B. Chopra
President, CEO, CFO and a Director
(604) 812-2344